...
首页> 外文期刊>Journal of Periodontology >Nitric oxide synthase inhibition prevents alveolar bone resorption in experimental periodontitis in rats.
【24h】

Nitric oxide synthase inhibition prevents alveolar bone resorption in experimental periodontitis in rats.

机译:一氧化氮合酶抑制作用可防止大鼠实验性牙周炎中牙槽骨的吸收。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Periodontitis is the most frequent cause of tooth loss in adults. Nitric oxide (NO) has been linked to bone resorption mechanisms during inflammation processes. The aim of this study was to investigate the effect of NOS (NO synthase) inhibitors in the alveolar bone loss in an experimental periodontitis disease (EPD) model. METHODS: Wistar rats were subjected to a ligature placement around the second upper left molars and were sacrificed at 11 days. Alveolar bone loss was evaluated by the sum of distances between the cusp tips and the alveolar bone along the axis of each molar root, subtracting from the contralateral side. Histopathological analysis was based on cell influx, alveolar bone, and cementum integrity. Leukogram was performed at 6 hours and 1, 7, and 11 days after the EPD induction. Groups were treated with the NOS inhibitors, aminoguanidine (AG) (2.5 to 10 mg/kg/d), or L-arginine methyl ester (L-NAME, 5 to 20 mg/kg/d) intraperitoneally (i.p.), 1 hour before the EPD induction and daily for 11 days. Controls received only saline (EPD group). As controls for L-NAME specificity, groups were co-treated with either L-arginine (150 to 600 mg/kg/d) or D-arginine (600 mg/kg/d) and L-NAME (20 mg/kg/d). Different groups were used for morphometric and histopathological analysis. RESULTS: Both L-NAME and AG significantly and dose-dependently inhibited the alveolar bone loss as compared to EPD group. L-NAME (20 mg/kg/d) reduced the alveolar bone loss by 50%, whereas AG (5 mg/kg/d) reduced it by 47% compared to EPD. This result was coupled to a significant reduction of cell influx to the periodontium, as well as to the preservation of alveolar bone and cementum, seen at histopathology, for both compounds. The co-administration of L-arginine, but not of D-arginine reversed L-NAME effects. CONCLUSION: These data provide evidence that NOS inhibitors prevent inflammatory bone resorption in experimental periodontitis.
机译:背景:牙周炎是成年人牙齿脱落的最常见原因。一氧化氮(NO)与炎症过程中的骨吸收机制有关。这项研究的目的是在实验性牙周炎疾病(EPD)模型中研究NOS(NO合酶)抑制剂在牙槽骨丢失中的作用。方法:Wistar大鼠在第二个左上磨牙周围进行结扎,并在第11天处死。牙槽骨损失是通过沿每个磨牙根轴的尖尖和牙槽骨之间的距离之和减去对侧而得出的。组织病理学分析基于细胞流入,牙槽骨和牙骨质完整性。在EPD诱导后6小时,1、7和11天进行白细胞检查。腹膜内(ip)用NOS抑制剂,氨基胍(AG)(2.5至10 mg / kg / d)或L-精氨酸甲酯(L-NAME,5至20 mg / kg / d)治疗各组,持续1小时在EPD启用之前,每天进行11天。对照组仅接受生理盐水(EPD组)。作为L-NAME特异性的对照,将各组与L-精氨酸(150至600 mg / kg / d)或D-精氨酸(600 mg / kg / d)和L-NAME(20 mg / kg / d)共同治疗d)。使用不同的组进行形态计量和组织病理学分析。结果:与EPD组相比,L-NAME和AG均显着且剂量依赖性地抑制了牙槽骨的丢失。与EPD相比,L-NAME(20 mg / kg / d)使牙槽骨损失减少了50%,而AG(5 mg / kg / d)使牙槽骨损失减少了47%。该结果与两种化合物在组织病理学上观察到的细胞流入牙周膜的大量减少以及牙槽骨和牙骨质的保存有关。 L-精氨酸的共同给药而不是D-精氨酸的共同给药逆转了L-NAME的作用。结论:这些数据提供了证据,表明NOS抑制剂可预防实验性牙周炎中炎症性骨吸收。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号